Overview


A stroke is a medical emergency. There are two types: ischemic stroke and hemorrhagic stroke. It is more common to suffer from an ischemic stroke. This is often caused by a blood blockage or plugging of a blood vessel in your brain. This prevents blood from flowing to your brain. Brain cells die within minutes. Stenosis, which is the narrowing of an artery, can also be a cause. Atherosclerosis is a condition in which plaque builds up within your arteries. A stroke caused by ischemia is when the blood supply to a part of the brain is cut off or disrupted. This stops brain tissue receiving oxygen and nutrients. Imaging tests are used in ischemia diagnosis to diagnose hemorrhage in acute stroke patients, gauge brain damage severity, and pinpoint the vascular cause of the ischemic deficit.Two major factors driving the growth in the acute ischemic stroke treatment and diagnosis market are large patient pools and an alarming rise in the stroke-prone population. The industry's development in the treatment and detection of ischemic strokes is also supported by technological advances.

Advanced CT and MRI technology allow for the identification of brain tissue that is permanently damaged and those that can be saved. This makes it easier to select individuals who may benefit from treatment. The market for ischemic stroke treatment is expected to grow at an accelerated pace over the forecast period, due to the increasing influence of telemedicine, electronic prescriptions, and electronic medical adherence. Market growth is driven by the rising incidence of diabetes, heavy tobacco use, and an aging population. The market growth will be limited by the high costs of treatment, inaccessible reimbursement policies, and the lack of expert knowledge. Rapid technological advances in surgical equipment and diagnosis are among the key factors that will drive the market growth for acute ischemic stroke treatment and diagnosis. The market is also expected to grow due to the increasing number of elderly people and the impact of telemedicine, e-prescription, and medical. The demand for minimally invasive treatments is expected to be a significant factor in the market's growth. A significant growth opportunity for the acute stroke treatment market is expected to be provided by favorable government initiatives and increased awareness about stroke and the available treatments.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Acute Ischemic Stroke Diagnosis and Treatment Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Acute Ischemic Stroke Diagnosis and Treatment Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  •  Abbott Laboratories
  •  Medtronic Plc
  •  Boston Scientific Corporation
  •  Cordis Corporation
  •  Koninklijke Philips N.V.
  •  GE Healthcare
  •  Siemens AG
  •  Stryker Corporation
  •  Genentech Inc
  •  MerckCo., Inc

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Type

  •  Diagnostics
    •  Computed Tomography (CT)
    •  Magnetic Resonance Imaging (MRI)
    •  Carotid Ultrasound
    •  Cerebral Angiography
    •  Electrocardiography
    •  Echocardiography
    •  Others
  •  Therapuetics
    •  Tissue Plasminogen Activator
    •  Anticoagulant
    •  Antiplatelet
    •  Antihypertensive

By Region

  •  North America
  •  Europe
  •  Asia-Pacific
  •  Latin America
  •  Middle East and Africa

  •  Tier 1 players- established companies in the market with a major market share
  •  Tier 2 players
  •  Emerging players which are growing rapidly
  •  New Entrants

  •  Growth prospects
  •  SWOT analysis
  •  Key trends
  •  Key data-points affecting market growth

  •  To provide with an exhaustive analysis on the Acute Ischemic Stroke Diagnosis and Treatment Market By Type and By Region.
  •  To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  •  To evaluate and forecast micro-markets and the overall market
  •  To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  •  To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  •  We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  •  The customization Mobility Care offered are free of charge with purchase of any license of the report
  •  You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Acute Ischemic Stroke Diagnosis and Treatment Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Acute Ischemic Stroke Diagnosis and Treatment Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Acute Ischemic Stroke Diagnosis and Treatment Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Acute Ischemic Stroke Diagnosis and Treatment Market, By Type Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Diagnostics
         1.1. Computed Tomography (CT)
         1.2. Magnetic Resonance Imaging (MRI)
         1.3. Carotid Ultrasound
         1.4. Cerebral Angiography
         1.5. Electrocardiography
         1.6. Echocardiography
         1.7. Others
        2. Therapuetics
         2.1. Tissue Plasminogen Activator
         2.2. Anticoagulant
         2.3. Antiplatelet
         2.4. Antihypertensive

  • 8.   North America Acute Ischemic Stroke Diagnosis and Treatment Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2024-2032

  • 9.   Latin America Acute Ischemic Stroke Diagnosis and Treatment Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2024-2032

  • 10.   Europe Acute Ischemic Stroke Diagnosis and Treatment Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.7. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2024-2032

  • 11.   Asia Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2024-2032

  • 12.   Middle East and Africa Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2024-2032

  • 13.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 14.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Abbott Laboratories
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Medtronic Plc
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Boston Scientific Corporation
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Cordis Corporation
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Koninklijke Philips N.V.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. GE Healthcare
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Siemens AG
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Stryker Corporation
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Genentech Inc
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. MerckCo., Inc
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 15.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 16.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients